Form 4: Anixa Biosciences Director Lewis H. Titterton Jr. Acquires 15,009 Shares
SEC Form 4 Filing
Anixa Biosciences Director Lewis H. Titterton Jr. purchased 15,009 shares of common stock at a price of $3.28 per share on April 9, 2024.
Summary
- On April 9, 2024, Lewis H. Titterton Jr., a director of Anixa Biosciences Inc., acquired 15,009 shares of the company's common stock.
- The purchase price was $3.28 per share.
- Following the transaction, Titterton directly owns 838,037 shares of Anixa Biosciences.
Sentiment
Score: 5
Explanation: The document itself is neutral, simply reporting a transaction. The sentiment depends on how investors interpret the insider buying activity.
Industry Context
Insider buying can sometimes be seen as a positive signal, indicating that a company insider believes the stock is undervalued. However, it's just one data point and should be considered alongside other factors when evaluating a company.
Key Dates
| Date | Description |
|---|---|
| 04/09/2024 | Date of transaction: Lewis H. Titterton Jr. purchased 15,009 shares of Anixa Biosciences. |
| 04/10/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.